SCIENTIFIC PUBLICATIONS

The following scientific publications were produced at AJC:

  1. Al-Habboubi, H., Tamim, H., Ameen, G., Almawi, W.Y.  2003.  A common mutation in 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in two Arab communities.  J. Thromb. Haemost.  1:  2246-2248.
  2. Hertting O, Khalil A, Jaremko G, Chromek M, Li YH, Bakhiet M, Bartfai T, Tullus K, Brauner A Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1beta-deficient mice. Clin Exp Immunol 131:2 225-33. 2003
  3. Chen Z, Yu S, Bakhiet M, Winblad B, Zhu J. The chemokine receptor CCR5 is not a necessary inflammatory mediator in kainic acid-induced hippocampal injury: evidence for a compensatory effect by increased CCR2 and CCR3. J Neurochem. 86: 61-68. 2003
  4. Al-Sallom FS, Al-Mahmeed A, Ismaeel A, Botta GA, Bakhiet M. Campylobacter-stimulated INT407 cells produce dissociated cytokine profiles. J Infect. 2003; 47: 217-24.
  5. Successful long-term treatment of hepatic carnitine palmitoyltransferase I deficiency and a novel  mutation. Stoler J. M. , Sabry M. A. , Hanley C. , Hoppel C. L. and Shih V. E. (2004) J Inherit Metab Dis. 27: 679-684.
  6. Qadi AA, Tamim H, Ameen G, Bu-Ali A, Al-Arrayed S, Fawaz NA, Almawi WY. Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control. 2004; 32: 493-495.
  7. disease. Almawi WY, Ameen G, Tamim H, Finan RR, Irani-Hakime N. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery. J Thromb Thrombolysis. 2004; 17: 199-205.
  8. Almawi WY, Busson M, Tamim H, Al-Harbi EM, Finan RR, Wakim-Ghorayeb SF, Motala AA.HLA class II profile and distribution of HLA-DRB1 and HLA-DQB1 alleles and haplotypes among Lebanese and Bahraini Arabs Clin Diagn Lab Immunol. 2004; 11: 770-774.
  9. Fawaz NA, Bashawery L, Al-Sheikh I, Qatari A, Al-Othman SS, Almawi WY. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia. Am J Hematol. 2004: 307-309.
  10. Tamim H, Musharrafieh U, Ramia S, Almawi WY, Al-Jisr T, Ayoub T, Nabulsi-Majzoub M, Kazma H, Baz EK. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant? Am J Infect Control. 2004; 32: 220-223.
  11. Almawi WY, Finan RR, Tamim H, Daccache JL, Irani-Hakime N. Am J Hematol. Differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene among the Lebanese population. 2004; 76: 85-87.
  12. Almawi WY, Melemedjian OK, Jaoude MM. On the link between Bcl-2 family proteins and glucocorticoid-induced apoptosis. J Leukoc Biol. 2004; 76: 7-14.
  13. Nasser RM, Rahi AC, Haddad MF, Daoud Z, Irani-Hakime N, Almawi WY. Outbreak of Burkholderia cepacia bacteremia traced to contaminated hospital water used for dilution of an alcohol skin antiseptic. Infect Control Hosp Epidemiol. 2004; 25: 231-239.
  14. Al-Habboubi H, Tamim H, Ameen G, Almawi WY. C677T and A1298C single nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene among Bahraini Arabs. Thromb Haemost. 2004; 91: 843-845.
  15. Al-Harbi EM, Abbassi AJ, Tamim H, al-Jenaidi F, Kooheji M, Kamal M, al-Mahroos S, al-Nasir F, Motala AA, Almawi WY. Specific HLA-DRB and -DQB alleles and haplotypes confer disease susceptibility or resistance in Bahraini type 1 diabetes patients. Clin Diagn Lab Immunol. 2004; 11: 292-296.
  16. Alhashimi N, Frithiof L, Brudvik P, Bakhiet M. CD40-CD40L expression during orthodontic tooth movement in rats. Angle Orthod. 2004; 74:100-105.
  17. Bakhiet M, Al-Salloom FS, Qareiballa A, Bindayna K, Farid I, Botta GA,. Induction of alpha and beta chemokines by intestinal epithelial cells stimulated with Campylobacter jejuni. J Infect. 2004; 48: 236-44.
  18. Liu Y, Li Z, Svaren-Quiding C, Cui J, Ozenci V, Bakhiet M.  Splenic denervation suppresses mRNA gene expression and protein production of IL-1beta and IL-6 by peritoneal macrophages in both Trypanosoma brucei brucei-infected and non-infected rats. Neuroimmunomodulation. 2004; 11: 113-8.
  19. Ahmed Sharafeldin, Eilhard Mix, Robert Harris Tomas Bittroff and Moiz Bakhiet. Prolonged Activation of Transcription Regulating Factors in Trypanosoma brucei Nuclear Proteins by Interferon-Stimulation. Acta Protozool. 2004: 43: 373 - 377
  20. Almawi WY, Keleshian SH, Borgi L, Fawaz NA, Abboud N, Mtiraoui N, Mahjoub T. Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs. J Thromb Thrombolysis. 2005; 20: 163-168.
  21. Wakim-Ghorayeb SF, Keleshian SH, Timson G, Finan RR, Najm P, Irani-Hakime N, Almawi WY. Factor V G1691A (Leiden) and prothrombin G20210A single-nucleotide polymorphisms in type 2 diabetes mellitus. Am J Hematol. 2005; 80: 84-86.
  22. Mahjoub T, Mtiraoui N, Tamim H, Hizem S, Finan RR, Nsiri B, Almawi WY. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages. Am J Hematol. 2005; 80: 12-19.
  23. Jishi AA, Krishnan PR, Almawi WY. Takayasu arteritis with high titre of antiphospholipid antibodies and MTHFR Polymorphism. J Thromb Thrombolysis. 2005; 20: 47-50.
  24. Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. J Thromb Thrombolysis. 2005; 19: 189-196.
  25. Al-Jenaidi FA, Wakim-Ghorayeb SF, Al-Abbasi A, Arekat MR, Irani-Hakime N, Najm P, Al-Ola K, Motala AA, Almawi WY. Contribution of selective HLA-DRB1/DQB1 alleles and haplotypes to the genetic susceptibility of type 1 diabetes among Lebanese and Bahraini Arabs. J Clin Endocrinol Metab. 2005; 90: 5104-5109.
  26. Mtiraoui N, Aboud N, Bouraoui H, Haizem S, Gris JC, Busson M, Tamim H, Almawi WY, Mahjoub T. Reduction in coagulation factor VII plasma levels by R353Q but not the -323P0/10 promoter polymorphism in healthy Tunisians. Am J Hematol. 2005; 79: 11-16.
  27. Mtiraoui N, Borgi L, Hizem S, Nsiri B, Finan RR, Gris JC, Almawi WY, Mahjoub T. Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol. 2005; 119:164-170.
  28. Fawaz NA, Tamim H, Almawi WY. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia. Am J Infect Control. 2005; 33: 189-191.
  29. Motala AA, Busson M, Al-Harbi EM, Khuzam MA, Al-Omari EM, Arekat MR, Almawi WY. Susceptible and protective human leukocyte antigen class II alleles and haplotypes in bahraini type 2 (non-insulin-dependent) diabetes mellitus patients. Clin Diagn Lab Immunol. 2005; 12: 213-217.
  30. Seidahmed M Z, Alyamani E A, Rashed MS, Saadallah A, Abdelbasit O B, Shaheed M,. Rasheed A, Hamid F A, Sabry M A. Total Truncation Of The Molybdopterin/Dimerization Domains Of SUOX Protein In an Arab Family with Isolated Sulphite Oxidase Deficiency. Am J Med Genet A. 2005;136A(2):205-20
  31. Ismaeel A, Al-Mahmeed A , Qareiballa A, Bakhiet M and Botta GA Effect of anti sub inhibitory concentration on cytolethal distending toxin production by Campylobacter jejuni. J Infect. 2005; 51: 144-149.
  32. Ahmed MR, Zaki M, Sabry MA, Higgs D, Vyas P, Wood W, Wickramasinghe SN. Evidence of  genetic heterogeneity in congenital dyserythropoietic anaemia type I. Br J Haematol. 2006; 133 (4) 444 -446
  33. Golbahar J, Fathi Z, Tamadon M. Distribution of 5,10-methylenetetrahydrofolate reductase (C667T) polymorphism and its association with red blood cell 5-methyltetrahydrofolate in the healthy Iranians. Clin Nutr. 2005; 24: 83-7.
  34. Golbahar, Emad Mohammad Masuadi, Mohammad Amin Aminzadeh Association of plasma total homocysteine and hypertension in the healthy Iranians , A cross sectional study. Abstract in 21st Annual Scientific Meeting and Exposition. Characterizing the Hypertension Phenotype, American Society of Hypertension May 16-20, 2006, New York City, USA
  35. Sameer Otoom, Moiz Bakhiet, Abdulmajeed Khan, Reginald Sequeira. Prolonged use of Phenytoin, Carbamazepine or Valproate  Monotherapy on Plasma Levels of Folate and B12: A comparison Between Epileptic Patients with or without Cardiovascular Disorders. Neuroendocrinology Letters. 2006; 27: 01-02.
  36. Moiz Bakhiet, Li-Ya Yu, Volkan Özenci, Abdulmajeed Khan and Fu-Dong Shi. Modulation of immune responses and suppression of experimental autoimmune myasthenia gravis by surgical denervation of the spleen. Clin Exp Immunol. 2006; 144: 290–298.
  37. Habib Al-yosif, Safa Taha, Moiz Bakhiet  Habib. Cytokine gene polymorphism in Bahraini patients with coronary heart disease. Arab Gulf Journal of Scientific Research. 2006: 24: 144-150.
  38. Golbahar J, Aminzadeh MA, Al-Shboul QM, Salah Kassab, Rezaian GR. Assoaction of methylenetetrahydrofolate reductase (C677T) polymorphism with hyperuricemia. Nutr Metab Cardiovasc Dis. 2007; 17:462-467.
  39. Golbahar J, Aminzadeh MA, Kassab SE, Omrani GR. Hyperhomocysteinemia induces insulin resistance in male Sprague-Dawley rats. Diabetes Res Clin Pract. 2007; 76: 1-5.
  40. Ali Al-Bahrani, Safa Taha, Husain Shaath and Moiz Bakhiet. TNF and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. Curr. Neurvascular Res.2007; 4: 31-37.
  41. Alyaa Mousa, Amani Al-Zaki, Safa Taha and Moiz Bakhiet. Induction of the chemokines CCL3, CCL3 and CCL5 in atherosclerotic patients. Am J Immunol. 3: 45-51, 2007.
  42. Moiz Bakhiet and Safa Taha. A novel nervous system-induced factor inducing immune responses in the spleen. Imm Cell Biol. 2008; 86: 688-699.
  43. Ahlam Al-Amri, Giuseppe Botta, Khaled Tabbara, Abdelrahman Ismaeel, Ali Al-Mahmeed, Ahmed Qareeballa, Khalid Bin Dayna, and Moiz Bakhiet. Campylobacter jejuni induces diverse kinetics and profiles of cytokine genes in INT-407 cells. Saudi Med J. 2008; 514-519.
  44. Alyaa Mousa, Amani Al-Zaki, Safa Taha and Moiz Bakhiet. Induction of the anti-inflammatory cytokines interleukin (IL)-10, IL-13 in atherosclerotic patients. Arab Gulf Journal of Scientific Research. 2008; 26: 86-94.
  45. Jamal Golbahar, Mansour Rahimi, Mohammad Bagger Tabei and Mohammad Amin Aminzadeh. Clinical risk factors and association of hyperhomocysteinemia with diabetic retinopathy in Iranian type 2 diabetes patients: A cross-sectional study from Shiraz, Southern Iran. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2008; 2: 192-201
  46. Alyaa Mousa, Amani Al-Zaki, Safa Taha and Moiz Bakhiet Induction of IL-18 in atherosclerotic patients: A role for Chlamydia pneumoniae. Medical Principles and Practice. Med Princ Pract. 2009; 18: 105-10. 2009.
  47. Almawi WY, Khan A, Al-Othman SS, Bakhiet M. 1.Case-control Study of methylenetetrahydrofolate reductase mutations and hyperhomocysteinemia and risk of stroke. J Stroke Cerebrovasc Dis. 18: 407-408. 2009.
  48. Al-Sindi K, Kamal N, Golbahar J. Efficacy of fine-needle aspiration biopsy in diagnosis of breast cancer: a retrospective study of 303 cases in Bahrain. Diagn Cytopathol. 37: 636-40. 2009
  49. Golbahar J, Al-Khayyat H, Hassan B, Agab W, Hassan E, Darwish A. Neonatal screening for congenital hypothyroidism: a retrospective hospital based study from Bahrain. J Pediatr Endocrinol Metab.23:39-44. 2010
  50. Ali Al-Bahrani, Habib Alyousef, Basem Mustafa, Meytham Majeed, Moiz Bakhiet. A possible role for Chlamydia pneumoniae in vaso-occlusive crisis in sickle cell disease. Bahrain Medical Bulletin, 32: 111-117. 2010.
  51. Ali Al-Bahrani, Safa Taha, Husain Shaath and Moiz Bakhiet Acute ischemic brain stroke is associated with the consequences of Chlamydia pneumoniae infection. J Bah Med Soc. 22: 146 – 150. 2010.
  52. Abdelhad Al-Bannawi, Khulood Al-Wesebai, Safa. Taha and Moiz Bakhiet Chlamydia pneumoniae induces chemokine expression by platelets in patients with atherosclerosis. Med Princ Pract. 20: 438. 2011